Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Clinical trial NCT06077656 · COMPLETED

Trial details

NCT number: NCT06077656
Sponsor: Inventprise Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2023-10-25
Primary completion: 2024-05-24
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.